Sattva S. Neelapu

The University of Texas MD Anderson Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

0.969Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A single-cell atlas of CD19 chimeric antigen receptor T cells

Cancer Cell(2023)10.1016/j.ccell.2023.08.015

Top 21%

0.969DataRank

Top 21%24 citations

Jared Henderson, Max J. Gordon, Irtiza Sheikh, Loretta J. Nastoupil, Jason R. Westin +8 more

Papers

Driven by 60 papers — median percentile 40. Top paper: “Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors”.

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

New England Journal of Medicine(2020)10.1056/nejmoa1910607

N/A

5.4DataRank · unranked

2164 citations

David Marín, Pinaki P. Banerjee, Homer A. Macapinlac, Philip A. Thompson, Rafet Başar +22 more

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00597

N/A

1.7DataRank · unranked

58 citations

R. Eric Davis, Lei Feng, Fredrick B. Hagemeister, Raphaël Steiner, Hun Ju Lee +24 more

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006240

N/A

1.4DataRank · unranked

47 citations

Collin K. Chin, Jason R. Westin, Nathan Fowler, Felipe Samaniego, Xiaoyun Cheng +12 more

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1215

N/A

1.3DataRank · unranked

41 citations

Haeseong Park, S. Greg Call, Kiran Madwani, Yasuhiro Oki, Vivek Subbiah +17 more

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells

Nature Communications(2022)10.1038/s41467-022-29669-8

N/A

1.3DataRank · unranked

43 citations

Agnès Gouble, Kathryn L. Black, Anna Skwarska, Ammar S. Naqvi, Deanne Taylor +28 more

Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease

Cancer Cell(2023)10.1016/j.ccell.2023.05.007

N/A

1.3DataRank · unranked

50 citations

Guangchun Han, Hans C. Lee, Krina K. Patel, Melody Becnel, Linghua Wang +24 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

1.0DataRank · unranked

800 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

A single-cell atlas of CD19 chimeric antigen receptor T cells

Cancer Cell(2023)10.1016/j.ccell.2023.08.015

Top 21%

0.969DataRank

Top 21%24 citations

Jared Henderson, Max J. Gordon, Irtiza Sheikh, Loretta J. Nastoupil, Jason R. Westin +8 more

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0.963DataRank · unranked

27 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

Nature Medicine(2022)10.1038/s41591-022-01731-4

N/A

0.849DataRank · unranked

286 citations

Michael Dickinson, Javier Munoz, Matthew L. Ulrickson, Catherine Thiéblemont, Olalekan O. Oluwole +12 more

Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial

The Lancet Haematology(2024)10.1016/s2352-3026(24)00133-9

N/A

0.833DataRank · unranked

29 citations

Jie Xu, Manoop S. Bhutani, Paolo Strati, Penny Q Fang, Susan Wu +22 more

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica(2022)10.3324/haematol.2022.281954

N/A

0.822DataRank · unranked

15 citations

Sushanth Gouni, Jason R. Westin, Lei Feng, Haleigh Mistry, Raphaël Steiner +16 more

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

Nature Medicine(2022)10.1038/s41591-022-01916-x

N/A

0.799DataRank · unranked

205 citations

Regis Perbost, Frederick L. Locke, Michael D. Jain, Sarah Turcan, Corinne Danan +17 more

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Nature Communications(2022)10.1038/s41467-022-29539-3

N/A

0.716DataRank · unranked

117 citations

Yanshuo Chu, Mercy Misoi, María E. Suarez‐Almazor, Jean Tayar, Huifang Lu +33 more

Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy

British Journal of Haematology(2023)10.1111/bjh.18677

N/A

0.668DataRank · unranked

18 citations

Samer A. Srour, Tito R. Mendoza, Meagan Whisenant, Ishwaria M. Subbiah, Elizabeth M. Gonzalez +9 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0.650DataRank · unranked

75 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights

Leukemia Research(2022)10.1016/j.leukres.2022.106928

N/A

0.644DataRank · unranked

20 citations

Nathaniel R. Wilson, Jayastu Senapati, Minas P. Economides, Monica L. Guzman, Sattva S. Neelapu +12 more

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Blood Advances(2022)10.1182/bloodadvances.2022008174

N/A

0.629DataRank · unranked

15 citations

Stefan Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu +16 more

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

Journal of Clinical Investigation(2022)10.1172/jci159402

N/A

0.612DataRank · unranked

58 citations

Paolo Strati, Ali Rezvan, Mohsen Fathi, Irfan Bandey, Jay R T. Adolacion +13 more

The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities

Journal of Critical Care(2020)10.1016/j.jcrc.2020.04.008

N/A

0.604DataRank · unranked

55 citations

Anne Rain Brown, Megan M. Herr, Sameer S. Kadri, Brian T. Hill, Prabalini Rajendram +22 more

Safety of CAR T-cell therapy in kidney transplant recipients

Blood(2020)10.1182/blood.2020008759

N/A

0.598DataRank · unranked

53 citations

Ranjit Nair, Swaminathan P. Iyer, Angelina Edwards, Sattva S. Neelapu, Raphaël Steiner +8 more

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010653

N/A

0.574DataRank · unranked

45 citations

Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun +23 more

Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications

Frontiers in Immunology(2021)10.3389/fimmu.2020.590494

N/A

0.568DataRank · unranked

43 citations

Ajay Sheshadri, Vickie R. Shannon, Dimitrios P. Kontoyiannis, Hagop M. Kantarjian, Guillermo Garcia‐Manero +20 more

Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling

Nature Cancer(2024)10.1038/s43018-024-00768-3

N/A

0.533DataRank · unranked

34 citations

Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An +16 more

Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8011

N/A

0.470DataRank · unranked

22 citations

Fateeha Furqan, Jason R. Westin, Luis Fayad, Sairah Ahmed, Hun Ju Lee +15 more

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007515

N/A

0.434DataRank · unranked

17 citations

Jingjing Cao, Jingwei Liu, Haopeng Yang, Timothy J. Davis, Shao-Qing Kuang +11 more

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.13935

N/A

0.385DataRank · unranked

12 citations

Jillian R. Gunther, Penny Fang, Mikaela Bankston, Sarah A. Milgrom, David Boyce-Fappiano +14 more

Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.3455

N/A

0.373DataRank · unranked

11 citations

Rishab Prakash, Paul Edelkamp, Mark Knafl, Anath C. Lionel, Ranjit Nair +94 more

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

eJHaem(2020)10.1002/jha2.1

N/A

0.292DataRank · unranked

6 citations

Chelsea C. Pinnix, Gordon Glober, Kaitlin M. Christopherson, Penny Fang, Hun Ju Lee +8 more

Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

Haematologica(2023)10.3324/haematol.2023.284453

N/A

0.284DataRank · unranked

4 citations

Naishu Kui, Ryan Sun, Jason R. Westin, Raphaël Steiner, Ranjit Nair +16 more

Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET–CT-documented First Remission

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.008

N/A

0.269DataRank · unranked

5 citations

Jillian R. Gunther, Penny Fang, Sarah A. Milgrom, Brinda Rao Korivi, Corey T. Jensen +16 more

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

Nature Communications(2025)10.1038/s41467-025-62509-z

N/A

0.241DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Ranjit Nair, Luis Fayad, Maria Alma Rodriguez +14 more

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016483

N/A

0.241DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Fredrick B. Hagemeister, Hun Ju Lee, Luis Fayad +16 more

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology(2024)10.1002/ajh.27283

N/A

0.241DataRank · unranked

4 citations

Hailin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson +18 more

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-205196

N/A

0.241DataRank · unranked

4 citations

Dai Chihara, Luis Fayad, Sattva S. Neelapu, Sairah Ahmed, Frederick Hagemeister +11 more

Impact of Pre-Treatment Liver-Related Factors on Clinical Outcomes after CAR T-Cell Therapy for Lymphoma

Blood(2024)10.1182/blood-2024-207616

N/A

0.104DataRank · unranked

1 citations

Sushanth Gouni, Lei Feng, Charles Gaulin, Amrit S. Gonugunta, Turçin Saridogan +22 more

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101650

N/A

0.104DataRank · unranked

1 citations

Sonal S. Noticewala, Susan Wu, Jillian R. Gunther, Ethan B. Ludmir, L. Jeffrey Medeiros +15 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma

Research Square(2023)10.21203/rs.3.rs-3315017/v1

N/A

0DataRank · unranked

0 citations

Szymon J. Szymura, Lin Wang, Tiantian Zhang, Soung-chul Cha, Zhenyuan Dong +13 more

A CAR against CAR for unintended consequences

Blood(2020)10.1182/blood.2019004172

N/A

0DataRank · unranked

0 citations

Sattva S. Neelapu

Editorial: CAR T-Cell Therapies in Hematologic Tumors

Frontiers in Oncology(2020)10.3389/fonc.2020.588134

N/A

0DataRank · unranked

2 citations

Benedetto Bruno, Sattva S. Neelapu, Marta Coscia

A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus

mBio(2024)10.1128/mbio.03413-23

N/A

0DataRank · unranked

18 citations

Sebastian Wurster, Karishma Bavisi, Thiago Aparecido da Silva, Paul Hauser, Jordan Kinnitt +5 more

Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial

Nature Communications(2024)10.1038/s41467-024-50880-2

N/A

0DataRank · unranked

18 citations

Lin Wang, Tiantian Zhang, Soung-chul Cha, Joo Y. Song, Zhenyuan Dong +14 more

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-208300

N/A

0DataRank · unranked

0 citations

Naishu Kui, Ryan Sun, Eslam Aboismail, Sanjit O. Tewari, Ajlan Al Zaki +26 more

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Blood Advances(2025)10.1182/bloodadvances.2024014476

N/A

0DataRank · unranked

10 citations

Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel +21 more

Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012401

N/A

0DataRank · unranked

0 citations

Amanda Brandt, Anath C. Lionel, Jared Henderson, Jason R. Westin, Sherry Adkins +9 more

Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma

Haematologica(2020)10.3324/haematol.2019.234385

N/A

0DataRank · unranked

31 citations

Christine M. Stellrecht, Hima V. Vangapandu, Mary Ayres, Benny Abraham Kaipparettu, Jun Hyoung Park +7 more

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0116

N/A

0DataRank · unranked

159 citations

Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain +24 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more

Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002328

N/A

0DataRank · unranked

197 citations

Sairah Ahmed, Partow Kebriaei, Loretta J. Nastoupil, Catherine M. Claussen, Grace Watson +10 more

T-cell potential for CD19-expressing malignancies revealed by multi-dimensional single-cell profiling

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.22.497245

N/A

0DataRank · unranked

1 citations

Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An +14 more

B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade

Frontiers in Immunology(2022)10.3389/fimmu.2022.794684

N/A

0DataRank · unranked

23 citations

Jason Roszik, Neeraj K. Saini, Vipul Kumar Singh, Karishma Bavisi, Zhiqiang Wang +11 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL

Hematological Oncology(2021)10.1002/hon.177_2880

N/A

0DataRank · unranked

0 citations

José Banchs, Efstratios Koutroumpakis, Melody Becnel, Cristina Gutiérrez, Paolo Strati +14 more

Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy

Frontiers in Oncology(2021)10.3389/fonc.2021.648655

N/A

0DataRank · unranked

37 citations

Jillian R. Gunther, Susan Wu, Bouthaina S. Dabaja, Loretta J. Nastoupil, Sairah Ahmed +3 more

Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.07.007

N/A

0DataRank · unranked

61 citations

Samer A. Srour, Meagan Whisenant, Ishwaria M. Subbiah, Tsun Hsuan Chen, Darcy Ponce +10 more

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV

Blood Advances(2023)10.1182/bloodadvances.2022009622

N/A

0DataRank · unranked

7 citations

Oren Pasvolsky, Lei Feng, Guofan Xu, Sanjit O. Tewari, Jaimole Varghese +9 more

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995

Top 100%

0DataRank

Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Sattva S. Neelapu

Indexed papers

Top data-sharing exemplar

Papers